- Study type
- Benefit
- Location
-
-
2 milesAny
- Completion time
-
20 minAny
- Keywords & Disciplines
Search results
-
Meditation for Poor Sleep and Stress/Trauma
University College London, GB
Have you experienced a stressful or traumatic event that still causes you distress? Do you have trouble sleeping? We are recruiting volunteers for a research study on the effects of meditation on poor sleep and stressor/trauma-related symptoms.
You will visit UCL four times over 10 weeks,...- 4 Month(s) to complete
- £50 Cash and 2 sleep reports
- Experiment
- 1-19 Torrington Pl, London WC1E 7HB, UK
04 March 2025 Requirements- Please complete a short survey on Qualtrics to see if you are eligible: https://qualtrics.ucl.ac.uk/jfe/form/SV_dgsqMYqvn8ZelTM
- Eligibility requirements: Age 18-35, trouble falling or staying asleep, experienced a stressful or traumatic event that continues to distress you, NOT currently in counselling/therapy, do NOT meditate once or more per month, have reliable daily access to the Internet
- Please note these are not the only criteria and you will need to undergo a telephone screening to confirm you are eligible to take part.
-
Psilocybin Study: Digital Intervention for Psychedelic Preparedness (DIPP)
University College London, GB
The DIPP study explores psilocybin's effects on well-being and cognition through a 21-day digital preparation program. Healthy participants complete daily reflective and mindfulness exercises before a supervised psilocybin session. The study involves four in-person visits at UCL: baseline...
- 5 Week(s) to complete
- Cash
- Experiment
- University College London, Gower St, London WC1E 6BT, UK
10 December 2024 Requirements- Aged 21–65 years.
- Limited psychedelic use (0–5 high-dose sessions; none in the past 6 months).
- Minimal meditation experience (≤10 sessions; no retreats or regular practice).
- Native English speaker.
- Normal or corrected-to-normal colour vision.
- Able and willing to provide informed consent.
- Able to engage with all study requirements, including in-person and remote sessions.
- UK resident registered with a primary care practice.
- Agree to allow research team contact with primary/secondary care teams if needed.
- Access to electronic devices for data entry.
- No current or past psychotic or bipolar disorder.
- No immediate family member with psychotic or bipolar disorder.
- No suicidal ideation or any attempts.
- No medically significant conditions (e.g., cardiovascular disease, uncontrolled hypertension).
- No use of medications interacting with psilocybin (e.g., antipsychotics, SSRIs, SNRIs, TCAs, mood stabilizers).
- No psychoactive drug use within 30 days (except nicotine or caffeine).
- No pregnancy, planning pregnancy, or breastfeeding.
- No participation in a drug trial within 6 months.
- No MRI contraindications (e.g., metal implants, pacemakers, severe claustrophobia).
- No medical contraindications (e.g., epilepsy, migraines, focal scalp sensitivity).